All terms in GO

Label Id Description
peptidyl-cystine sulfhydration GO_0044525
The modification of a peptidyl-cystine residue in a protein by the addition of sulfur, to form peptidyl-cysteine persulfide.
formation of peptidyl-cystine persulfide by sulphur transfer from free cysteine GO_0044526
The modification of a peptidyl-cystine residue in a protein by the transfer of a sulfur atom from a free cysteine (in the process converting the free cysteine to alanine) to the peptidyl-cysteine to form peptidyl-cysteine persulfide.
formation of peptidyl-cystine persulfide by sulphur transfer from H2S GO_0044527
The modification of a peptidyl-cystine residue in a protein by the direct addition of H2S, followed by the removal of 2 protons to form peptidyl-cysteine persulfide.
regulation of mitochondrial mRNA stability GO_0044528
Any process that modulates the propensity of mitochondrial mRNA molecules to degradation. Includes processes that both stabilize and destabilize mitochondrial mRNAs.
regulation of mRNA stability GO_0043488
Any process that modulates the propensity of mRNA molecules to degradation. Includes processes that both stabilize and destabilize mRNAs.
regulation of mitochondrial rRNA stability GO_0044529
Any process that modulates the propensity of mitochondrial rRNA molecules to degradation. Includes processes that both stabilize and destabilize mitochondrial rRNAs.
regulation of rRNA stability GO_0044357
Any process that modulates the propensity of rRNA molecules to degradation. Includes processes that both stabilize and destabilize rRNAs.
L-arabitol catabolic process to xylulose 5-phosphate GO_0019590
The chemical reactions and pathways resulting in the breakdown of L-arabitol to form xylulose 5-phosphate. L-arabitol is converted into L-xylulose, which is then phosphorylated to L-xylulose-5-phosphate. This is converted to D-xylulose-5-phosphate via the intermediate L-ribulose-5-phosphate.
L-arabitol catabolic process GO_0051158
The chemical reactions and pathways resulting in the breakdown of L-arabitol, the pentitol derived from arabinose or lyxose by reduction of the aldehyde group.
GO_0019591 GO_0019591
mannitol catabolic process GO_0019592
The chemical reactions and pathways resulting in the breakdown of mannitol, the alditol derived from D-mannose by reduction of the aldehyde group.
mannitol metabolic process GO_0019594
The chemical reactions and pathways involving mannitol, the alditol derived from D-mannose by reduction of the aldehyde group.
hexitol catabolic process GO_0019407
The chemical reactions and pathways resulting in the breakdown of hexitols, any alditol with a chain of six carbon atoms in the molecule.
GO_0019582 GO_0019582
galactonate metabolic process GO_0019583
The chemical reactions and pathways involving galactonate, the anion of galactonic acid, an organic acid derived from the sugar galactose.
galactonate catabolic process GO_0019584
The chemical reactions and pathways resulting in the breakdown of galactonate, the anion of galactonic acid.
aldonic acid catabolic process GO_0046176
The chemical reactions and pathways resulting in the breakdown of aldonic acid, a monocarboxylic acid with a chain of three or more carbon atoms, derived from an aldose by oxidation of the aldehydic group.
glucuronate metabolic process GO_0019585
The chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group.
uronic acid metabolic process GO_0006063
The chemical reactions and pathways involving uronic acid, any monocarboxylic acid formally derived by oxidizing to a carboxyl group the terminal hydroxymethylene group of either an aldose with four or more carbon atoms in the molecule, or of any glycoside derived from such an aldose.
envenomation resulting in positive regulation of vasoactive intestinal polypeptide receptor activity in another organism GO_0044520
A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the resultant positive regulation of the activity of a vasoactive intestinal polypeptide receptor in the bitten organism.